CLOV stock price has been impacted by macroeconomic factors, with bond yields easing. Lower rates tend to improve sentiment for growth-focused health insurers whose valuations are sensitive to discount rates. Within CLOV’s Insurance segment, the Insurance Benefits Expense Ratio (BER) was 82.8% in the third quarter of 2024, which contracted 50 basis points (bps) year over year. Insurance medical care ratios (MCR) was 78% in the third quarter of 2024, which also contracted 50 bps year over year. Momentum investing is essentially an exception to the idea of "buying low and selling high." Investors following this style of investing are usually not interested in betting on cheap stocks and waiting long for them to recover. Instead, they believe that "buying high and selling higher" is the way to make far more money in lesser time. In the last five trading sessions, CLOV stock price volatility has decreased, lowering the implied options premiums. Traders may see opportunities in writing covered calls against a stable price base.